Study confirms vCJD could be transmitted by blood transfusion

August 29, 2008

A 9-year study in sheep has added to the evidence that vCJD can be transmitted through blood transfusion in humans

The findings underline the importance of precautions against vCJD transmission, such as the Government decision in 2004 to ban blood donations from anyone who had received a blood transfusion since 1980.

The study published in Blood, the journal of the American Society of Hematology, looked at BSE transmission between sheep through infected blood with the aim of quantifying how vCJD - the human form of BSE - could be spread through transfusions.

Researchers (Fiona Houston, Nora Hunter and colleagues) at the Neuropathogenesis Unit at the Institute of Animal Health, which is now part of The Roslin Institute, University of Edinburgh, found that the likelihood of BSE being transmitted between sheep through transfusion of infected sheep blood was 36 per cent, with rates of 43 per cent found for scrapie.

Fiona Houston, now at the University of Glasgow, who led the research, said: "It is apparent that the stage of disease incubation in infected donors played a large role in the likelihood of transmission. The longer that BSE or scrapie had been carried by donors, the greater the likelihood of the disease being transmitted with transfusions of infected blood."

While cases of vCJD are tailing off there are concerns that up to 4,000 people could be carrying the disease in the UK, which could then be transmitted through infected blood causing further infections.

Scientists are working to develop a test for vCJD that can be used before symptoms develop and a filter is also being trialled to remove prions - infective proteins - from donated blood.

Dr Houston said: "The study shows that, for sheep infected with BSE or scrapie, transmission rates via blood transfusion can be high, particularly when donors are in the later stages of infection. This suggests that blood transfusion represents an efficient route of transmission for these diseases and justifies the current control measures put in place to safeguard human blood supplies.

"While it may not correlate directly to what happens in the human population, due to factors such as species differences in genetic susceptibility to disease, it provides greater insight into the role of how vCJD may be carried through infected blood. By understanding how vCJD can be transmitted through blood transfusions, we can ensure the most effective control measures to minimise human to human infection."

BSE is one of a group of rare neurodegenerative disorders called transmissible spongiform encephalopathies (TSEs), which include scrapie and vCJD. Of 22 sheep that received BSE infected blood, eight showed evidence of infection. Nine out of 21 sheep receiving scrapie-infected blood developed the disease.

To date 167 cases of vCJD have been recorded in the United Kingdom, of which three patients are thought to have received vCJD through infected blood.

University of Edinburgh

---

---

	Statistical Aspects of BSE and vCJD: Models for Epidemics (Chapman & Hall/CRC Monographs on Statistics & Applied Probability) by C A Donnelly (Author), N M Ferguson (Author) Bovine Spongiform Encephalopathy (BSE) or "mad cow disease," first diagnosed in late 1986, is transmitted through feed, indirect horizontal transmission, apparently maternally and possibly horizontally, through cattle-to-cattle contact or a contaminated environment. With no ante-mortem test yet developed, the only information available about BSE is from case surveillance and a limited number of experiments. Only through careful and rigorous modeling and analysis can reliable estimates of past infection and predictions of future cases be made. The modeling developed for BSE utilizes a range of techniques from statistics, ecology, and demography that is of interest both as a case study and for providing tools for other modeling projects. Statistical Aspects of BSE and vCJD: Models for...
	Leukotrap Removes vCJD Prions.: An article from: Membrane & Separation Technology News by Business Communications Company, Inc. (Publisher) This digital document is an article from Membrane & Separation Technology News, published by Business Communications Company, Inc. on December 1, 2004. The length of the article is 539 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Leukotrap Removes vCJD Prions. Publication: Membrane & Separation Technology News (Newsletter) Date: December 1, 2004 Publisher: Business Communications Company, Inc. Volume: 23 Issue: 3 Page: NA Distributed by Thomson...
	UK blood service warns vCJD test could cut donations.(Creutzfeldt-Jakob disease)(Brief Article): An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on July 27, 2001. The length of the article is 583 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: UK blood service warns vCJD test could cut donations.(Creutzfeldt-Jakob disease)(Brief Article) Publication: Transplant News (Newsletter) Date: July 27, 2001 Publisher: Transplant Communications, Inc. Volume: 11 Issue: 14 Page: NA Article Type: Brief Article Distributed by Thomson...
	FDA widens barrier on blood donations to prevent spread of vCJD in US.(variant Creutzfeld-Jakob disease)(Brief Article): An article from: Transplant News by Transplant Communications, Inc. (Publisher) This digital document is an article from Transplant News, published by Transplant Communications, Inc. on September 30, 2001. The length of the article is 560 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: FDA widens barrier on blood donations to prevent spread of vCJD in US.(variant Creutzfeld-Jakob disease)(Brief Article) Publication: Transplant News (Newsletter) Date: September 30, 2001 Publisher: Transplant Communications, Inc. Volume: 11 Issue: 18 Page: NA Article Type: Brief Article Distributed by Thomson...
	vCJD risk from plasma very small.(NEWS FROM THE FDA)(variant Creutzfeldt-Jakob disease)(Brief article): An article from: Internal Medicine News by Unavailable (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on August 1, 2009. The length of the article is 320 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: vCJD risk from plasma very small.(NEWS FROM THE FDA)(variant Creutzfeldt-Jakob disease)(Brief article) Author: Unavailable Publication: Internal Medicine News (Magazine/Journal) Date: August 1, 2009 Publisher: International Medical News Group Volume: 42 Issue: 14 Page: 8(1) Article Type: Brief article Distributed by Gale, a part of Cengage...
	S250 INTRODUCTION TO THE COURSE AND TOPIC 1 BSE/VCJD by P. MURPHY' 'RICHARD HOLLIMAN (Author)
	Overall Blood Supply Strategy With Regard to Variant Creutzfeldt-jakob Disease (Vcjd): Report of the Working Group Commissioned by the German Federal ... (Transfusion Medicine and Hemotherapy 2006) by S Karger Pub (Publisher)
	Information on Mad Cow Disease by Grasshopper Books Information on Mad Cow Disease short information for all
	The BSE inquiry : return to an order of the Honourable the House of Commons dated October 2000 for the report, evidence and supporting papers of the inquiry into the emergence and identification of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) and the action taken in response to it up to 20 March 1996 by Nicholas Addison Phillips Bridgeman, June. ; Ferguson-Smith, M. A. Phillips of Worth Matravers (Author)
	Animal Pharm: One Man’s Struggle to Discover the Truth about Mad Cow Disease and Variant CJD by Mark Purdey (Author), Nigel Purdey (Editor) Mark Purdey's life changed one day in 1984 when a Ministry of Agriculture inspector told him he must administer a toxic organophosphate pesticide to his dairy herd. Passionately committed to organic farming and convinced of the harmful effects of chemicals in the environment, he refused to comply. 'It was as if my whole life became focused', he explained later. Before they had a chance to prosecute, Purdey took the Ministry to court and won his case. These experiences led him to challenge the orthodox line on the origins of Mad Cow Disease and its human counterpart variant CJD. Could the insecticide used in the official programme have precipitated the spread of the disease?Purdey's quest to discover the truth was hampered at every turn by government bureaucracies and self-serving...